AU2007318209A1 - Avian derived erythropoietin - Google Patents

Avian derived erythropoietin Download PDF

Info

Publication number
AU2007318209A1
AU2007318209A1 AU2007318209A AU2007318209A AU2007318209A1 AU 2007318209 A1 AU2007318209 A1 AU 2007318209A1 AU 2007318209 A AU2007318209 A AU 2007318209A AU 2007318209 A AU2007318209 A AU 2007318209A AU 2007318209 A1 AU2007318209 A1 AU 2007318209A1
Authority
AU
Australia
Prior art keywords
epo
composition
isolated mixture
glycosylated
ifn
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2007318209A
Other languages
English (en)
Inventor
Alex J. Harvey
Robert D. Ivarie
Guodong Liu
Julie A. Morris
Jeffrey C. Rapp
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Georgia Research Foundation Inc UGARF
Synageva Biopharma Corp
Original Assignee
University of Georgia Research Foundation Inc UGARF
Synageva Biopharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Georgia Research Foundation Inc UGARF, Synageva Biopharma Corp filed Critical University of Georgia Research Foundation Inc UGARF
Publication of AU2007318209A1 publication Critical patent/AU2007318209A1/en
Assigned to UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC., SYNAGEVA BIOPHARMA CORP reassignment UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. Alteration of Name(s) of Applicant(s) under S113 Assignors: SYNAGEVA BIOPHARMA CORP, UNIVERSITY OF GEORGIA RESEARCH FOUNDATION
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/465—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from birds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/505—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2007318209A 2006-11-09 2007-10-10 Avian derived erythropoietin Abandoned AU2007318209A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US85789606P 2006-11-09 2006-11-09
US60/857,896 2006-11-09
US87760106P 2006-12-28 2006-12-28
US60/877,601 2006-12-28
US91850407P 2007-03-16 2007-03-16
US60/918,504 2007-03-16
PCT/US2007/021643 WO2008057161A1 (fr) 2006-11-09 2007-10-10 Érythropoiétine dérivée des oiseaux

Publications (1)

Publication Number Publication Date
AU2007318209A1 true AU2007318209A1 (en) 2008-05-15

Family

ID=39364811

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2007318209A Abandoned AU2007318209A1 (en) 2006-11-09 2007-10-10 Avian derived erythropoietin

Country Status (6)

Country Link
EP (1) EP2076530A4 (fr)
JP (1) JP2010509327A (fr)
KR (1) KR20090090328A (fr)
AU (1) AU2007318209A1 (fr)
CA (1) CA2668487A1 (fr)
WO (1) WO2008057161A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ585555A (en) * 2008-01-07 2012-08-31 Synageva Biopharma Corp Transgenic chicken containing a transgene comprising a glycosyltransferase coding sequence
US20120264688A1 (en) * 2009-09-23 2012-10-18 Walter Hinderer Process for the purification of recombinant human erythropoietin (epo), epo thus purified and pharmaceutical compositions comprising same
TW201408695A (zh) * 2012-08-30 2014-03-01 Body Organ Biomedical Corp 重組載體及應用其而產生之轉基因魚卵與生物材料
WO2017169978A1 (fr) * 2016-03-31 2017-10-05 株式会社カネカ Procédé de production d'érythropoïétine féline purifiée
WO2018039163A1 (fr) * 2016-08-23 2018-03-01 Alexion Pharmaceuticals, Inc. Procédé de purification d'une protéine hétérologue à partir d'un blanc d'œuf

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7129390B2 (en) * 1997-10-16 2006-10-31 Avigenics, Inc Poultry Derived Glycosylated Interferon Alpha 2b
US20040019923A1 (en) * 1997-10-16 2004-01-29 Ivarie Robert D. Exogenous proteins expressed in avians and their eggs
EP2133421A1 (fr) * 1997-10-16 2009-12-16 University Of Georgia Research Foundation, Inc. Oiseaux transgéniques et production de protéines dans l'albumen des oeufs
ES2273497T3 (es) * 1998-06-15 2007-05-01 Gtc Biotherapeutics, Inc. Proteina de fusion de la albumina serica humana de eritropoyetina analoga.
EP1438401B1 (fr) * 2001-09-18 2011-06-15 Synageva BioPharma Corp. Production d'oiseaux transgeniques par injection cytoplasmique
WO2006112147A1 (fr) * 2005-03-30 2006-10-26 Kaneka Corporation Oiseau transgenique produisant de l’erythropoietine et procede pour l’obtenir

Also Published As

Publication number Publication date
EP2076530A4 (fr) 2010-04-07
KR20090090328A (ko) 2009-08-25
JP2010509327A (ja) 2010-03-25
EP2076530A1 (fr) 2009-07-08
CA2668487A1 (fr) 2008-05-15
WO2008057161A1 (fr) 2008-05-15

Similar Documents

Publication Publication Date Title
US7511120B2 (en) Glycosylated G-CSF obtained from a transgenic chicken
US7534929B2 (en) Avians expressing heterologous protein
US7338654B2 (en) Glycosylated interferon alpha obtained from a transgenic chicken
US8563803B2 (en) Method of making protein in an egg of a transgenic chicken
US20140336362A1 (en) Avian Derived Antibodies
US8124732B2 (en) Composition comprising isolated human CTLA4-Fc fusion protein produced in a transgenic chicken
AU2007318209A1 (en) Avian derived erythropoietin
US20090074718A1 (en) Avian derived erythropoietin
US7812127B2 (en) Glycosylated human G-CSF
AU2007227723B2 (en) Glycosylated G-CSF
US20090105462A1 (en) Glycosylated erythropoietin
US7803362B2 (en) Glycosylated interferon alpha
CN101595125A (zh) 禽类衍生的红细胞生成素
CN101405299A (zh) 糖基化的g-csf

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period